EVE Placement Update
Filed with ASX · · 3 pages · English
EVE Health Group Limited on 6ix
Earlier from EVE Health
- EVE Raises $0.9m to Advance Drug Reformulation Strategy
- Trading Halt
- EVE Advances Reformulated Drugs Targeting Global Markets
- Appendix 4D and Half Year Report
- Launch of Libbo and Activation of Men's Health Platform
Later from EVE Health
- Prospectus
- Investor Presentation
- Appointment of Chief Executive Officer
- Eve Initiates Pilot Clinical Study for Libbo ED Film
- Quarterly Activities/Appendix 4C Cash Flow Report - Amended
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health